Human CLL cells also express higher levels of the A2a adenosine receptor than normal B cells, and exogenous adenosine has been shown to protect CLL cells from spontaneous or drug-induced apoptosis [12]. This evidence concerns the gene ADORA2A and B-cell chronic lymphocytic leukemia.